INDIANAPOLIS, June 24, 2018 /PRNewswire/ -- People with type 2 diabetes new to treatment with a glucagon-like peptide-1 (GLP-1) receptor agonist (RA) had better blood sugar control, were more likely
Growth Capitalist (https://growthcapitalist.com/2018/06/real-world-data-show-advantages-in-people-treated-with-lillys-once-weekly-trulicity-dulaglutide-compared-to-those-treated-with-liraglutide-and-exenatide-qw/)
INDIANAPOLIS, June 24, 2018 /PRNewswire/ -- People with type 2 diabetes new to treatment with a glucagon-like peptide-1 (GLP-1) receptor agonist (RA) had better blood sugar control, were more likely